But if weight loss drugs can improve cardiometabolic health, as it seems they can, and fulfil even half of what is being claimed for them, then this must be one of the biggest breakthroughs in medical ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Some business leaders might be tested in having to respond to the different challenges and crisis situations that have ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

Congress is pushing companies like Ozempic and Wegovy, which make weight loss drugs that have changed the lives of millions ...

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Rupert Everett has no plans to use Ozempic despite admitting that he has a self-described “big tummy.” Speaking to The Times ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's pricing ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.